Merve Denizli

Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer

Pınar Kanlikilicer, Recep Bayraktar, Merve Denizli et al. · EBioMedicine · 2018 · 215 citations · Full text

GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma

Amr Ahmed El‐Arabey, Merve Denizli, Pınar Kanlikilicer et al. · Cellular Signalling · 2020 · 121 citations · Full text

Tumor-associated Macrophages, Hgsoc Cell Lines, Oncogenic Agent +15

Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models

Pınar Kanlikilicer, Bülent Özpolat, Burcu Aslan et al. · Molecular Therapy — Nucleic Acids · 2017 · 78 citations · Full text

Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs

Mohammed H. Rashed, Pınar Kanlikilicer, Cristian Rodriguez‐Aguayo et al. · Oncotarget · 2017 · 68 citations · Full text

The Reliability and Validity of Lymphedema Quality of Life Questionnaire-Leg in Turkish Patients with Lower Limb Lymphedema

Pınar Borman, Ayşegül Yaman, Merve Denizli et al. · Lymphatic Research and Biology · 2019 · 26 citations